ACAB enters PIPE agreements for $11.2M with Abpro Bio and Celltrion for business combination

Abpro Holdings, Inc.

Abpro Bio subscribes for 622,467 shares at $10/share ($6.2M total), with $4.2M portion via loan forgiveness.
Celltrion subscribes for 500,000 shares at $10/share ($5M total).
Both investors receive incentive shares: 1,244,934 for Abpro Bio and 1,000,000 for Celltrion.
Closing conditioned on previously announced business combination with Abpro Corporation.
Celltrion gets investor rights including director nominee designation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.